Kovitz Investment Group Partners LLC Increases Holdings in The Cooper Companies, Inc. $COO

Kovitz Investment Group Partners LLC lifted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 27,418.1% during the third quarter, HoldingsChannel reports. The firm owned 782,340 shares of the medical device company’s stock after purchasing an additional 779,497 shares during the quarter. Kovitz Investment Group Partners LLC’s holdings in Cooper Companies were worth $53,637,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently added to or reduced their stakes in the stock. Buckhead Capital Management LLC lifted its holdings in shares of Cooper Companies by 14.3% during the 3rd quarter. Buckhead Capital Management LLC now owns 58,930 shares of the medical device company’s stock worth $4,040,000 after acquiring an additional 7,368 shares during the last quarter. First American Bank purchased a new stake in Cooper Companies during the third quarter valued at about $1,646,000. Rakuten Investment Management Inc. bought a new stake in Cooper Companies during the third quarter worth about $11,341,000. Amundi boosted its holdings in shares of Cooper Companies by 35.5% in the 2nd quarter. Amundi now owns 1,331,480 shares of the medical device company’s stock worth $97,225,000 after purchasing an additional 348,652 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA increased its position in shares of Cooper Companies by 96.9% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock valued at $212,519,000 after purchasing an additional 1,525,693 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently weighed in on COO. The Goldman Sachs Group restated a “sell” rating and issued a $73.00 target price on shares of Cooper Companies in a research report on Friday, January 9th. JPMorgan Chase & Co. lifted their price target on shares of Cooper Companies from $66.00 to $78.00 and gave the stock a “neutral” rating in a research note on Friday, December 5th. Barclays set a $98.00 price objective on shares of Cooper Companies and gave the stock an “overweight” rating in a report on Monday, January 26th. Citigroup reaffirmed a “neutral” rating and set a $88.00 target price (up previously from $72.00) on shares of Cooper Companies in a report on Monday, December 8th. Finally, KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research note on Friday, December 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $90.77.

Insider Buying and Selling

In other Cooper Companies news, Director Cynthia L. Lucchese acquired 1,784 shares of the company’s stock in a transaction on Monday, December 22nd. The stock was acquired at an average price of $84.06 per share, for a total transaction of $149,963.04. Following the acquisition, the director owned 9,445 shares in the company, valued at $793,946.70. This represents a 23.29% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Maria Rivas acquired 1,000 shares of the business’s stock in a transaction dated Thursday, December 18th. The stock was acquired at an average price of $82.13 per share, for a total transaction of $82,130.00. Following the completion of the transaction, the director owned 11,141 shares in the company, valued at approximately $915,010.33. The trade was a 9.86% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased 16,014 shares of company stock valued at $1,304,416 over the last ninety days. Corporate insiders own 1.98% of the company’s stock.

Cooper Companies Stock Up 0.5%

Shares of NASDAQ COO opened at $84.07 on Friday. The firm’s fifty day moving average is $82.12 and its 200 day moving average is $75.25. The Cooper Companies, Inc. has a 52 week low of $61.78 and a 52 week high of $92.84. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30. The company has a market cap of $16.48 billion, a price-to-earnings ratio of 44.72, a PEG ratio of 2.40 and a beta of 1.03.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The business had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.06 billion. During the same quarter in the prior year, the company posted $1.04 EPS. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.